title: [Discriminant function analysis in the assessment of laboratory test data in the correction of traditional therapy for mild icteric form of viral hepatitis B in children with food allergy].
abstract: The purpose of this investigation was to define the efficiency of inclusion of antihistamines (suprastin or tavegil), enzyme drugs (pancreatin or mesim forte) and their combinations into therapy for a mild icteric form of acute viral hepatitis B (VHB) in children with food allergy (FA). Among the examinees, there were 61 children with FA who had experienced a mild icteric form of VHB and who received traditional therapy at the age of 3-14 years. Of them, 36 children were additionally given antihistamines (n = 7), enzyme drugs (n = 20), and their combination (n = 9). About half the children (47.54%) were boys. Blood samples were biochemically tested in children for bilirubin and enzymes 1, 3, 6, 9, and 12 months after their hospital discharge. The similar laboratory tests were carried out in 20 healthy children--a comparison (control) group. Analysis of discriminant functions stated the high efficiency of inclusion of enzyme drugs, or antihistamines in particular, or their combinations with enzyme drugs, that considerably reduce the time it takes to normalize the complexes of the indices of a blood biochemical test for bilirubin and enzymes.
authors.forename: L S
authors.initials: LS
authors.lastname: Kalagina
authors.forename: V F
authors.initials: VF
authors.lastname: Rossokhin
authors.forename: T N
authors.initials: TN
authors.lastname: Efremenko
authors.forename: T I
authors.initials: TI
authors.lastname: Zobkova
mesh_terms: D000293:Adolescent; D000410:Alanine Transaminase / Q000097:blood*; D001663:Bilirubin / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D002974:Clemastine / Q000627:therapeutic use; D016002:Discriminant Analysis; D004359:Drug Therapy, Combination; D005029:Ethylenediamines / Q000627:therapeutic use; D005260:Female; D005512:Food Hypersensitivity / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006509:Hepatitis B / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006633:Histamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010194:Pancreatin / Q000627:therapeutic use*
chemical_list: D005029:Ethylenediamines; D006633:Histamine Antagonists; C004664:chloropyramine; D010194:Pancreatin; D002974:Clemastine; D000410:Alanine Transaminase; D001663:Bilirubin